Hennion & Walsh Asset Management, Inc. Tg Therapeutics, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

$2.1 Billion
Q4 2024

A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 97,633 shares of TGTX stock, worth $2.85 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

97,633

Previous 98,629 1.01%

Holding current value

$2.85 Million

Previous $2.31 Million 27.41%

% of portfolio

0.14%

Previous 0.11%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$21.31 - $35.09 $21,224 - $34,949	-996 Reduced 1.01%	97,633 $2.94 Million
Q3 2024 Oct 22, 2024	SELL	$17.21 - $25.28 $47,155 - $69,267	-2,740 Reduced 2.7%	98,629 $2.31 Million
Q2 2024 Jul 19, 2024	SELL	$13.32 - $19.19 $1.11 Million - $1.6 Million	-83,446 Reduced 45.15%	101,369 $1.8 Million
Q1 2024 Apr 17, 2024	BUY	$13.02 - $21.3 $348,428 - $570,009	26,761 Added 16.93%	184,815 $2.81 Million
Q4 2023 Jan 10, 2024	BUY	$6.68 - $18.81 $212,878 - $599,437	31,868 Added 25.25%	158,054 $2.7 Million
Q3 2023 Oct 27, 2023	SELL	$8.36 - $26.5 $29,845 - $94,605	-3,570 Reduced 2.75%	126,186 $1.05 Million
Q2 2023 Aug 09, 2023	SELL	$15.48 - $35.0 $28,978 - $65,520	-1,872 Reduced 1.42%	129,756 $3.22 Million
Q1 2023 Apr 20, 2023	SELL	$10.23 - $19.34 $39,017 - $73,762	-3,814 Reduced 2.82%	131,628 $1.98 Million
Q4 2022 Jan 12, 2023	SELL	$5.01 - $11.83 $341,381 - $806,096	-68,140 Reduced 33.47%	135,442 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $63,582 - $116,869	13,913 Added 7.34%	203,582 $1.21 Million
Q2 2022 Jul 19, 2022	BUY	$3.74 - $10.66 $224,957 - $641,188	60,149 Added 46.44%	189,669 $806,000
Q1 2022 Apr 26, 2022	BUY	$7.81 - $20.45 $90,478 - $236,913	11,585 Added 9.82%	129,520 $1.23 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $214,639 - $501,436	14,121 Added 13.6%	117,935 $2.24 Million
Q3 2021 Nov 12, 2021	SELL	$21.78 - $40.45 $49,854 - $92,590	-2,289 Reduced 2.16%	103,814 $3.46 Million
Q2 2021 Aug 13, 2021	BUY	$32.5 - $48.96 $476,060 - $717,166	14,648 Added 16.02%	106,103 $4.12 Million
Q1 2021 May 17, 2021	BUY	$41.61 - $54.3 $3.81 Million - $4.97 Million	91,455 New	91,455 $4.41 Million

Others Institutions Holding TGTX

# of Institutions

336

Shares Held

87.6M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.

Account

Hennion & Walsh Asset Management, Inc. Tg Therapeutics, Inc. Transaction History